CRDF 8-K 2026-07-16

Cardiff Oncology, Inc. (CRDF) 8-K dated 2026-07-16 — accession 0001193125-26-305467. This URL is the filing, not the CRDF hub.

Cardiff Oncology, Inc. (CRDF) is a biotechnology company listed on US.

Cardiff Oncology, Inc. filed a 8-K on 2026-07-16. Accession 0001193125-26-305467.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.

Not investment advice. The CRDF SEC hub lists recent forms. The stock page is the research view.